WebSome of my recent results that demonstrate my capabilities include: • President’s Club co-leader for FY 2024, finished #3 of 30 territories nationally. growth) with Cubist. • Ranked #2 in ... WebThe average salary for Cubist Pharmaceuticals employees is $89,000 per year. Visit PayScale to research Cubist Pharmaceuticals salaries, bonuses, reviews, benefits, and more!
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average …
WebJan 21, 2015 · outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) at a purchase price of $102.00 per share. As of the tender offer … Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion). See more Cubist was founded in May 1992 by John K. Clarke, Paul R. Schimmel, Ph.D. and Barry M. Bloom, Ph.D, all of whom were also directors. Cubist appeared on Fortune 2010’s List of fastest growing companies, and was named to … See more The company developed Cubicin (daptomycin) for injection, the first antibiotic in a class of anti-infectives called lipopeptides. In 2011, Cubist settled a patent litigation with Teva Pharmaceutical Industries regarding Cubicin. In April 2011 it reached a deal … See more how high will bynd stock go
Optimer Pharmaceuticals LinkedIn
WebApr 11, 2024 · Cubist Systematic Strategies LLC now owns 40,323 shares of the biotechnology company’s stock valued at $2,092,000 after buying an additional 2,900 shares during the last quarter. WebCubist Pharmaceuticals was founded in 1992 in Lexington, Massachusetts. They are a pharmaceutical company whose products provide anti-infective and antibiotic treatments and therapies. Having been in business for just over 15 years, Cubist Pharmaceuticals has decided to focus the marketing of their products specifically on the United States. WebJul 30, 2013 · Cubist Pharmaceuticals, Inc. Eileen C. McIntyre, 781-860-8533 Vice President, Investor Relations [email protected] or MEDIA: Julie DiCarlo, 781-860-8063 Senior Director, Corporate Communications [email protected] or Trius Therapeutics Contacts: MEDIA: MSLGROUP Laura Kempke, 781-684-0770 … how high will exxon stock go